Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c893 |
|---|---|
| Identifier | NCT05767021 |
| Trial Title | A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis|Ulcerative Colitis Chronic |
| Interventions | DRUG: Mirikizumab|DRUG: Mirikizumab |
Participant Information
| Sponsor | Eli Lilly and Company |
|---|---|
| City | Litchfield Park |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2023-05-17 |
|---|---|
| Primary Completion Date | 2024-08-09 |
| Completion Date | 2025-09-25 |